Ragdoll Health Testing Explained
Ragdolls are one of the most beloved cat breeds in the world, prized for their gentle temperament, striking blue eyes, and tendency to go limp with relaxation when held. But beneath that docile exterior lies a set of breed-specific health concerns that responsible breeders must actively screen for. Understanding these health tests is not just important for breeders — it is essential knowledge for any buyer who wants to ensure their future companion comes from a program that prioritizes longevity and quality of life over appearance alone.
Hypertrophic cardiomyopathy (HCM) is the single most critical health concern in Ragdolls, and the breed has one of the highest incidences of this condition among all pedigreed cats. HCM causes the heart muscle to thicken progressively, reducing the heart's ability to pump blood efficiently and eventually leading to congestive heart failure, arterial thromboembolism (blood clots, often to the hind legs), or sudden cardiac death. A DNA test exists for the Ragdoll-specific MYBPC3 R820W mutation, and while testing for this mutation is an important first step, it only identifies one known genetic pathway to HCM. Cats that test negative for the DNA mutation can still develop HCM through other genetic or environmental mechanisms. This is why annual echocardiograms performed by a board-certified veterinary cardiologist remain the gold standard for HCM screening in Ragdoll breeding programs. Both DNA testing and echo screening should be performed — they are complementary, not interchangeable. Any Ragdoll breeder who relies solely on the DNA test and skips echocardiograms is providing incomplete cardiac screening.
Blood type testing is a health consideration that is uniquely important in Ragdolls and often overlooked by less experienced breeders. Ragdolls have a significantly higher prevalence of blood type B compared to most other cat breeds — estimates suggest that 15 to 20 percent of Ragdolls are type B, compared to less than 5 percent in the general domestic cat population. This matters enormously for breeding because of a condition called neonatal isoerythrolysis (NI). When a type B queen is bred to a type A tom, the resulting type A kittens can absorb anti-A antibodies through the mother's colostrum (first milk) during the initial 16 to 24 hours of nursing. These antibodies attack the kitten's red blood cells, causing rapid hemolytic anemia that is frequently fatal. Responsible Ragdoll breeders blood-type every cat in their program and carefully plan pairings to avoid NI risk. At minimum, they ensure that type B queens are not bred to type A males, or they have protocols in place to prevent at-risk kittens from nursing the mother's colostrum during the critical first day.
Polycystic kidney disease (PKD) is a genetic condition that causes fluid-filled cysts to develop in the kidneys, gradually destroying kidney tissue and leading to renal failure. While PKD is most commonly associated with Persians and Persian-derived breeds, Ragdolls can carry the autosomal dominant PKD1 mutation, and a reliable DNA test is available to identify it. Since only one copy of the gene is needed to cause the disease, any positive-testing cat should be removed from a breeding program. FeLV (feline leukemia virus) and FIV (feline immunodeficiency virus) testing should be performed on all breeding cats and ideally confirmed negative before any cat enters the cattery. Both are retroviruses that compromise the immune system and can be transmitted between cats through close contact, shared food bowls, mutual grooming, and bite wounds. A responsible closed cattery tests all cats upon acquisition and retests if any new cat is introduced or if a cat has any potential exposure to outside animals.
When evaluating a Ragdoll breeder, request documentation for every test discussed in this article. Specifically, you should see the Ragdoll HCM DNA test result (MYBPC3 R820W — clear, heterozygous, or homozygous), the most recent echocardiogram report with the cardiologist's name and date (performed within the last 12 months for active breeding cats), the blood type for both parents, the PKD1 DNA test result, and FeLV/FIV test results. These documents should show the registered name and microchip or registration number of the cat being tested, allowing you to confirm they correspond to the actual parents of your kitten. A breeder who provides this documentation without hesitation is demonstrating the transparency that defines a responsible program. A breeder who deflects, provides excuses, or claims that testing is unnecessary because their "lines are clean" is cutting corners that could cost you thousands in veterinary bills — or worse, the heartbreak of losing a young cat to a preventable condition.